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Background The aim of this study was to build risk charts for the assessment of cardiovascular mortality of the CUORE
project, an Italian longitudinal study, and to compare them with the systematic coronary risk evaluation (SCORE) project
charts for low risk European countries.
Design Random population samples enrolled in the 1980s and 1990s in Italy were included in the analysis: 7520 men and
13 127 women aged 35–69 years without previous cardiovascular events and with a mean follow-up period of 10 years for
cardiovascular disease. ICD-9 codes of death certificates similar to those of the SCORE project were considered when they
appear as first cause of death.
Methods Sex-stratified Cox proportional hazard model including age, systolic blood pressure, ratio between total and HDL
cholesterol, and smoking habit as risk factors was used to assess cardiovascular mortality.
Results Analysis showed that all risk factors included in the model were statistically significant. The corresponding area
under the receiver operating characteristic curve was 0.825 (95% confidence interval: 0.803–0.846) for men and 0.850
(0.823–0.877) for women. The CUORE project charts yielded similar results to the corresponding charts of the SCORE
project: Lin’s coefficient was 0.929 for men and 0.935 for women.
Conclusion The comparison between CUORE and SCORE mortality risk charts shows that SCORE charts reflect quite
well the Italian cardiovascular mortality and, correspondingly, Italian cohorts of the CUORE project are quite representative
of European countries at low risk for cardiovascular mortality. Eur J Cardiovasc Prev Rehabil 17:403–409 c 2010 The
European Society of Cardiology
European Journal of Cardiovascular Prevention and Rehabilitation 2010, 17:403–409
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Introduction
Global risk assessment has become an accepted compo-
nent of clinical guidelines and recommendations for
cardiovascular prevention [1–3]. In Europe, systematic
coronary risk evaluation (SCORE) risk charts are recom-
mended in clinical practice as a valid tool to estimate
cardiovascular risk. They were built using data from the
SCORE study, a pooling project of several European
longitudinal studies, with base-line examination con-
ducted from 1967 to 1991. Different charts for high and
low risk European populations were published by Conroy
et al. in 2003 [4].
In Italy, the CUORE project, funded by the Italian
Ministry of Health, was launched at the end of 1990s,
with the aim of building a database of cardiovascular risk
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factors collected within longitudinal studies started in the
1980s and 1990s using standardized procedures and
methods and implementing the follow-up of cardiovas-
cular mortality and morbidity for assessing cardiovascular
risk in the adult Italian population [5–8].
The aims of the analysis presented here are to build
CUORE project risk charts for the assessment of cardio-
vascular mortality and to compare them with those
developed by SCORE for low risk European countries.
This may lead to a possible collaboration with the SCORE
project and, eventually, to the inclusion of the CUORE
project data in the 10-year risk SCORE update for cardio-
vascular disease (CVD) in low risk regions of Europe.
Materials and methods
Population samples
The CUORE project pooled standardized data from
random population samples in Northern, Central, and
Southern Italy: 20 647 (7520 men and 13 127 women)
aged 35–69 years without previous cardiovascular events
were included in the analysis and followed-up until
2002 (10-year mean period) for CVD. As women usually
develop less CVD events than men, more women than
men were involved in the study. Data collection
procedures and methods were standardized and are
comparable with those of the MONICA project [9–11].
Participation rates were 64–78% except for one cohort
(MATISS 1987 with 40%). A detailed description of these
cohorts has already been published [12–15] and
is available on the CUORE project web site (www.cuore.iss.it).
Baseline measurements
Risk factors were assessed by standardized procedures
[9–11]. Blood pressure (right arm) was measured twice
with a mercury sphygmomanometer, participant sitting,
after 5min of rest; systolic blood pressure (SBP) or
diastolic blood pressure were recorded (first and fifth
phase of Korotkoff sounds); the first and second
measurements were averaged for analyses. Total choles-
terol and HDL cholesterol (TC, HDL-C) were assayed on
serum in four different laboratories under the quality control
of reference laboratories and measurements were carried
out using the colorimetric enzymatic method. Informa-
tion was collected by questionnaire on cigarette smoking,
personal history of myocardial infarction, stroke, diabetes
mellitus, hospitalization for cardiovascular events, and
medication.
Cardiovascular events registration/validation
Standardized methods were used to identify and validate
suspected events. Major cardiovascular events, in parti-
cular myocardial infarction, stroke, revascularization treat-
ment (bypass or angioplasty), and sudden death, were
identified through record linkage between mortality and
hospital discharge registers over December 2002 [14,15].
In this analysis, only cardiovascular mortality was consi-
dered using the following ICD-9 codes when they appear
as first cause of death: ICD-9 codes 401–414 and
426–443, with the exception of the 430.0 ICD-9 code
for definitely nonatherosclerotic causes of death. Instan-
taneous death (ICD-9, 798.1) and death within 24 h
of symptoms onset (ICD-9, 798.2) were also classified as
cardiovascular deaths. Similar codes were considered for
the SCORE analysis [4].
Statistical analysis
Cox proportional hazard models were used to estimate
10-year risk score of cardiovascular mortality and corre-
sponding areas under the receiver operating characteristic
(ROC) curve were calculated. Risk factors included,
as for SCORE, were age, SBP, smoking habit, TC or
TC/HDL-C ratio. Sex-stratified models were performed to
consider the whole dataset for the estimation of risk factor
coefficients assuming that risk factors do not significantly
vary in their effect from men to women. Cohort-adjustment
and interactions between risk factors were studied.
To compare CUORE and SCORE charts, Lin’s con-
cordance coefficients were calculated between each cell
of the CUORE risk charts and the corresponding one of
the SCORE risk charts for low risk European countries.
Agreement between frequency in the cardiovascular risk
categories (<1%, 1–4%, 5–9%, Z 10%) according to
CUORE and SCORE charts was assessed by sex and
smoking habit.
Results associated to a P value r 0.05 were considered
statistically significant. Statistical analyses were per-
formed using SAS software, release 8.1 (SAS Institute
Inc., Cary, North Carolina, USA).
Results
Among 7520 men and 13 127 women free of CVD
at baseline, 308 and 181 cardiovascular deaths were iden-
tified, respectively (99 385 and 144 797 individuals years).
Sex-stratified model with only TC was considered not
statistically significant to allow a consistent assessment of
10-year risk of fatal CVD necessary to build the corres-
ponding charts. Only charts referring to TC/HDL-C ratio
were shown.
Cardiovascular risk chart considering total cholesterol
The Cox model of CUORE project is reported in Table 1
as model 1. Age, SBP, and smoking habit were statistically
significant risk factors whereas total cholesterol was not.
Cardiovascular risk chart considering total
cholesterol/HDL-cholesterol ratio
Cohort-adjustment did not result in improvement of
risk prediction. Interaction between age and smoking was
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found and included in the final model. All risk factors
included in the cardiovascular mortality Cox model of the
CUORE project were statistically significant (Table 1,
model 2). The corresponding area under the ROC curve
was 0.825 (95% confidence interval: 0.803–0.846) for men
and 0.850 (0.823–0.877) for women.
The CUORE project charts yielded similar results to the
corresponding charts of the SCORE project for low risk
European countries (Figs 1 and 2). In the CUORE chart,
the risk range for men was 0–20% and 0–25% for non-
smoking and smoking men, respectively (0–15% and 0–28%
for the SCORE chart); the risk range for women was 0–9%
and 0–11% (0–8% and 0–15% for the SCORE chart). Lin’s
coefficient was 0.929 for men and 0.935 for women. For
men, 81% of cardiovascular risk categories (<1%, 1–4%,
5–9%, Z 10%) showed agreement between CUORE and
SCORE charts: 79 and 82% for non-smoking and smoking
men, respectively, with a tendency for the non-smoking
men’s CUORE chart to predict a lower risk than the
SCORE chart and the opposite for the charts for men who
smoked. For women, 91% of cardiovascular risk categories
agreed between the CUORE and SCORE charts: 96%
for non-smoking women and 86% for smoking women.
Discussion
The CUORE project used standardized data collection
methods and validated and classified cerebrovascular and
coronary fatal and nonfatal events using the MONICA
project diagnostic criteria [9–11]. These characteristics
allowed comparison between the CUORE charts for
10-year risk assessment of cardiovascular mortality and the
SCORE project charts for low risk European countries.
Within the CUORE project, national risk charts were
developed in 2004 to assess the probability of developing
major fatal and nonfatal cardiovascular events [5–7] and
are nowadays recommended by the Italian Ministry
of Health for cardiovascular risk assessment of the
general adult Italian population in primary prevention
[8]. In the light of this, the aim of the present analysis is
not to introduce other charts in Italian clinical practice
or evaluate which model, CUORE or SCORE, yields the
better assessment of Italian CVD mortality risk, but to
test homogeneity of CUORE and SCORE results for the
assessment of cardiovascular mortality in low risk regions
of Europe. This is the main reason for the interest in
comparing risk charts and not models accuracy.
The sex-stratified model with TC was considered not
statistically significant to allow a consistent assessment of
10-year risk of fatal CVD necessary to build the corres-
ponding charts. This was probably because of the low
impact of total cholesterol for CVD risk in Italian women
compared with other CVD risk factors, as shown in earlier
CUORE project analyses [14,15], in combination with the
low number of cardiovascular deaths that occurred among
women during the follow-up. With future inclusion of new
cohorts, similar analyses may be successfully performed.
Considering the sex-stratified model with TC/HDL ratio,
all risk factors were statistically significant and a good level
area under the ROC curve was found. The comparison
between CUORE and SCORE charts yielded homo-
geneous results: a very high association between esti-
mated risks was found for corresponding charts, as well as
an high agreement between the frequency of cardiovascular
risk categories.
Not surprisingly, CUORE and SCORE charts are homo-
geneous: Italy is one of the low risk European countries
and some CUORE project cohorts enrolled in the 1980s
and considered in this analysis are those previously
included in the RIFLE study, which represented the
dataset for Italy used to build SCORE charts for low risk
European countries [16,17]. Nevertheless, the contribu-
tion in terms of number of individuals involved in both
studies (2065 men and 2448 women) is quite low: 2% of
Table 1 Cox proportional hazard models, CUORE project cohorts, men and women aged 35–69 years free of earlier CVD at baseline
Stratified by men and women
Model 1 Model 2
Variable Coefficient STD ER HR 95% CI P value Coefficient STD ER HR 95% CI P value
Age, years 0.133 0.007 1.14 1.13 1.16 <0.001 0.146 0.010 1.16 1.14 1.18 <0.001
Systolic blood pressure
(mmHg)
0.019 0.002 1.02 1.02 1.02 <0.001 0.019 0.002 1.02 1.02 1.02 <0.001
Total cholesterol (mg/dl) 0.0005 0.001 1.00 1.00 1.00 NS
Total cholesterol/HDL-choles-
terol
0.104 0.026 1.11 1.06 1.17 <0.001
Smoking (yes, no) 0.424 0.104 1.53 1.25 1.87 <0.001 2.315 0.854 10.13 1.90 53.97 <0.01
Age and smoking interaction – 0.032 0.014 0.97 0.94 1.00 <0.05
Men S (10) =0.987 G (m) = 9.631 S (10) = 0.987 G (m) = 10.803
Women S (10) =0.996 G (m) = 9.473 S (10) = 0.996 G (m) = 10.539
S (10) = 10-year survival evaluated at mean value of risk factors. G (m) is the linear combination of the risk factor averages or of the prevalence in each category for the
corresponding coefficients. CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; NS, not significant; STD ER, standard error.
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the individuals used for risk factor coefficients assess-
ment in SCORE charts (205 178 men and women from
high and low risk European countries) and 6 and 8% of
men and women, respectively, used for low risk baseline
survival function assessment in SCORE charts (37 183
men and 31 598 women from low risk European
countries). In addition, mortality follow-up of the RIFLE
study used for SCORE charts lasted 6 years, while the
follow-up considered in the CUORE project was 10 years.
More discrepancies were found among non-smoking
men/women compared to smoking men/women. Small
differences are probably because of the differences in
risk factors level and CVD death rate between cohorts
used in this analysis and those used for SCORE charts:
the first are only Italian cohorts, while the second
included Italy, Belgium, and Spain [4,18]. In addition,
to have a sufficient number of individuals and fatal events
and to consider the same age range used in earlier
CUORE studies [5–7,14,15], CUORE analysis included
individuals aged 35–69 years, instead of individuals aged
40–65 years as in SCORE, which may cause small
differences in risk estimation among younger and older
age classes.
Main differences in risk charts are in the very high-risk
levels, well above the threshold of 5% recommended by
the European guidelines [3]. Discrepancies at these risk
levels are much less important than discrepancies closer
to the threshold (e.g. 3–7%), as the individual is already
classified as high risk and treatment decisions will not be










3 4 4 4 5
5 6 6 7
8 8 9 10
11 12 13 15
12
8
6 6 7 8 9
9 10 11 12
13 14 16 18
19 20 22 2518 20
10
7
5 5 6 6 7
7
7
5 5 6 6 7
8 8 9 10
8 9 10









2 2 3 3 3
4 4 4 5
120 10-year risk of fatal CVD 
15% and over180 3 6
4
3
2 2 2 3 3
3 3 4 4
4 5 5 6
6 7 8 9
2
2
1 1 1 1 2
2 2 2 2
2
1
1 1 1 1 1
1 1 1 1 1
0
0 0 0 0 0
0 0 0 0 0
0 0 0 0 0
0 0 1 1 1
1 1 1 1 1
1
0 0 0 0 1
1 1 1 1
1 1 1 2
1 1 2 2
2 2 2 2 3
2
2 2 2 2 2
1 1 1 1 2
3 3 3 3
4 4 4 5
3 3 3 3
4 4 5 5
10 – 14%160

























Total cholesterol/HDL cholesterol ratio
3 4 5 6 7 3 4 5 6 7
Ten-year risk of fatal cardiovascular disease. Chart based on results in men from Cox model with total cholesterol/HDL-cholesterol ratio stratified
by sex. CUORE project cohorts, 35–69 aged, free of earlier cardiovascular disease (CVD).
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Some differences between the CUORE and SCORE
methods used to build risk charts are worth discussing.
The choice of applying the Cox proportional hazard
model, instead of the Weibull models used by SCORE, is
because of the fact that it was also used in earlier CUORE
analyses [5–7,14,15]. SCORE charts were cross checked
by comparison with Cox models, thus the use of Cox
regression models in this analysis should not compromise
comparisons.
In the CUORE analysis, the hazard functions were based
on person’s time under observation rather than on person’s
age as in the SCORE functions. The approach used to
build CUORE charts is commonly used in many
epidemiological analyses, where it is not useful to estimate
survival for a follow-up time longer than study’s follow-up
period, and prevents the effect of splitting time on risk
into two different variables: age at screening and time
since screening.
To reach a sufficient number of fatal events allowing
a consistent assessment of 10-year risk of fatal CVD,
CUORE charts were calculated in one single step using
CVD mortality as end-point instead of combining two
separate risk estimations (coronary heart disease and all
noncoronary atherosclerotic CVD) as for SCORE. SCORE
models were cross-checked by examined models
in which total cardiovascular risk was calculated in one
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The assessment of absolute risk represents the first step
for a correct and useful primary prevention at population
level. Ideally, each country should have its own risk
function but, because of the lack of data from prospective
studies in every European country, the development
of the SCORE general European risk function, which can
be applied to areas with approximately similar CVD
incidence rates, proved to be a more practical approach.
As country variations have been observed in cardiovas-
cular mortality [19–21], SCORE charts were developed
for high-risk and low-risk regions of Europe. Recalibration
methods have been recommended as they seem to work
effectively in different settings [22–24]. Some European
countries developed a score system to assess CVD risk
in their own country using recalibration methods starting
from Framingham or SCORE models [25,26]; others
provided a validation of developed tools [27]; others
developed a function based on cohorts enrolled in their
countries [5–7,28,29]. The lack of recent studies involv-
ing a sufficiently large population, an array of risk factors
information and a follow-up of cardiovascular events
collected using standardized procedures, in particular, in
low risk populations, where large sample sizes are requi-
red to produce a sufficient number of events, are the
main reasons for the interest in testing the homogeneity
of CUORE and SCORE data to study a possible inclusion
of the CUORE project data in the 10-year risk SCORE
update for CVD in low-risk regions of Europe.
Conclusion
Some considerations arise from the results of the CUORE
project presented here: the comparison between
CUORE and SCORE mortality risk charts shows that
SCORE charts reflect Italian cardiovascular mortality
quite well and, correspondingly, Italian cohorts of the
CUORE project are quite representative of low risk
European countries cardiovascular mortality. This could
represent a proof of reliability of both populations of
reference and methodologies and suggest inclusion of
CUORE project cohorts in SCORE chart update for use
in low-risk regions of Europe. Given the importance of
estimating risk of nonfatal events, especially in those
regions at low risk of cardiovascular mortality where
nonfatal coronary heart disease and stroke are the main
cause of morbidity, the inclusion of nonfatal events in the
updated version could also be considered. The updated
risk charts could include cohorts tested in this analysis
and those with more recent baseline enrolled between
1998 and 2002 (Osservatorio Epidemiologico Cardio-
vascolare) [30].
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